Insights from analysts' 12-month price targets are revealed, presenting an average target of $137.82, a high estimate of $155.00, and a low estimate of $120.00. This current avera ...

In the last three months, 7 analysts have published ratings on Celldex Therapeutics CLDX -0.35% Get Free Report , offering a ...

Biomea Fusion (NASDAQ:BMEA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at D. Boral Capital in a research note issued to investors on Wednesday,Benzinga ...

Fantasy baseball analyst Scott Pianowski reveals the players he's found himself clicking on the most this draft season.

Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...

Shares of Luminar Technologies (LAZR) are up 8% after the company reported stronger-than-expected fourth-quarter 2024 sales ...

The two simultaneous Incyte trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.

As Elon Musk continues to take an outsized and controversial role in the US government, reports of harassment of Tesla owners ...

Operator Good day, and welcome to the FedEx third quarter fiscal 2025 earnings call. All participants are in listen-only mode ...

The so-called “magnificent seven” US tech stocks that have dominated investor attention and stock market capitalisation for ...

Money still talks but flexibility, meaningful work and educational and wellbeing support are all ranked as priorities by ...

BlackRock is pushing for staking in Ethereum ETFs, calling it a necessary step to make the funds more attractive to investors ...